Form 8-K - Current report:
SEC Accession No. 0001140361-25-006423
Filing Date
2025-02-28
Accepted
2025-02-28 06:56:24
Documents
20
Period of Report
2025-02-26
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ny20044490x2_8k.htm   iXBRL 8-K 41906
2 EXHIBIT 4.1 ny20044490x2_ex4-1.htm EX-4.1 109206
3 EXHIBIT 4.2 ny20044490x2_ex4-2.htm EX-4.2 111384
4 EXHIBIT 5.1 ny20044490x2_ex5-1.htm EX-5.1 18419
5 EXHIBIT 10.1 ny20044490x2_ex10-1.htm EX-10.1 190497
6 EXHIBIT 10.2 ny20044490x2_ex10-2.htm EX-10.2 44911
7 EXHIBIT 99.1 ny20044490x2_ex99-1.htm EX-99.1 12878
11 ny20044490x2_ex5-1img001.jpg GRAPHIC 26633
  Complete submission text file 0001140361-25-006423.txt   832528

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA pdsb-20250226.xsd EX-101.SCH 3988
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE pdsb-20250226_lab.xml EX-101.LAB 21966
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pdsb-20250226_pre.xml EX-101.PRE 16048
23 EXTRACTED XBRL INSTANCE DOCUMENT ny20044490x2_8k_htm.xml XML 4076
Mailing Address 303A COLLEGE ROAD EAST PRINCETON NJ 08540
Business Address 303A COLLEGE ROAD EAST PRINCETON NJ 08540 800-208-3343
PDS Biotechnology Corp (Filer) CIK: 0001472091 (see all company filings)

EIN.: 264231384 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37568 | Film No.: 25682507
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)